Xaydarova Shaxnoza Elmuratovna 2025. The Possibilities of CRISPR–Cas9 Technology in the Treatment of Hereditary Diseases. American Journal of Biomedicine and Pharmacy. 2, 10 (Oct. 2025), 105–107. DOI:https://doi.org/10.51699/ajbp.v2i10.1616.